Updated Recommendation
A new evidence synthesis was published:2018, Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV
View latest version (2018)Bibliographic information
Recommendation
For infants and children infected with HIV younger than 3 years, abacavir (ABC) + lamivudine (3TC) + zidovudine (AZT) is recommended as an option for children who develop TB while on an ART regimen containing nevirapine (NVP) or lopinavir/r. Once TB therapy has been completed, this regimen should be stopped and the initial regimen should be restarted
Recommended in favor
Strong
Certainty of evidence
Moderate
Also Featured In
This recommendation also appears in the following guidelines:
Consolidated guidelines on general HIV care and the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach